Capital One Financial Weighs in on EyePoint Pharmaceuticals, Inc.’s Q1 2024 Earnings (NASDAQ:EYPT)
EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT – Free Report) – Capital One Financial raised their Q1 2024 earnings per share (EPS) estimates for EyePoint Pharmaceuticals in a report issued on Monday, May 6th. Capital One Financial analyst T. Chiang now expects that the company will post earnings of ($0.32) per share for the quarter, up from their […]
More Stories
Nexstar Media Group (NASDAQ:NXST) Price Target Cut to $198.00
Nexstar Media Group (NASDAQ:NXST – Get Free Report) had its price target lowered by analysts at Guggenheim from $200.00 to...
Critical Survey: Cybin (CYBN) versus Its Rivals
Cybin (NYSE:CYBN – Get Free Report) is one of 443 publicly-traded companies in the “Biotechnology” industry, but how does it...
Nuvalent (NASDAQ:NUVL) PT Raised to $125.00
Nuvalent (NASDAQ:NUVL – Get Free Report) had its target price hoisted by equities research analysts at JPMorgan Chase & Co....
Baidu, Inc. (NASDAQ:BIDU) Given Consensus Rating of “Moderate Buy” by Brokerages
Baidu, Inc. (NASDAQ:BIDU – Get Free Report) has earned an average recommendation of “Moderate Buy” from the eighteen brokerages that...
NRG Energy, Inc. (NYSE:NRG) Receives Average Recommendation of “Hold” from Brokerages
NRG Energy, Inc. (NYSE:NRG – Get Free Report) has been given an average recommendation of “Hold” by the eight ratings...
NIKE (NYSE:NKE) Price Target Cut to $77.00
NIKE (NYSE:NKE – Free Report) had its target price cut by JPMorgan Chase & Co. from $80.00 to $77.00 in...